Optival Health Solutions, a subsidiary of Medplus, has received two suspension orders for drug licenses at its Bangalore stores due to regulatory violations, resulting in a potential revenue loss of approximately Rs 0.31 lacs and Rs 0.34 lacs as of March 4, 2025.